Delivery Order SPE2DB20D1109-SPE2DB25FP32B

Award Date 7/1/25
Potential Completion Date 7/2/25
Potential Value $42K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $4,377.73 and an ultimate completion date of April 21, 2025. The contract is a firm-fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $5,777.75 and an ultimate completion date of September 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $10,492.26 and is for a firm fixed price delivery order with a period of performance through May 12, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $2,980.75 and an ultimate completion date of June 9, 2025. It is a firm fixed-price contract without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablet 60s. The contract has a ceiling value of $22,163.78 and an ultimate completion date of August 30, 2024. It is a firm-fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $3,218.78 and a completion date of September 5, 2024. It is a firm-fixed-price contract, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $29,480.21 and is a firm fixed price contract with a completion date of September 19, 2024. The contract is not set aside for any specific socioeconomic program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $8,400.12 and is a firm fixed-price delivery order with a period of performance through June 10, 2025. The contract is not set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $27,866.17 and runs through March 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $12,445.39 and is a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. The contract is not set aside and is for the provision of this specific pharmaceutical product to support federal medical procurement needs, particularly for military and veteran...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FP32B
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The order has a firm fixed price contract type and a ceiling value of $42,462.07. The contract is not set aside and has an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is part of the company's ongoing role as a critical vendor supporting federal medical procurement needs, particularly for the military and veteran healthcare systems.

Generated 9/30/25, 10:04 AM